Cipla Launches ‘CIPtest’ Rapid Antigen Detection Test for COVID-19 Diagnosis Kumar Jeetendra | December 16, 2020 Mumbai, India; December 16, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced its partnership with the Premier Medical Corporation Private Limited for commercialisation of the rapid antigen test kits for COVID-19 in India. The company will commence supply from this week. This is Cipla’s second launch in the diagnostics …
